col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Wiley: Journal of the European Academy of Dermatology and Venereology
  original article Date Title Authors   All Authors
1 [GO] 2021―Jul―23 Prevalence and characteristics of dermatological manifestations in COVID-19 positive dermatologists: Report from a web-based survey in India Deepak Jakhar, Anupam Das, Subuhi Kaul, Ishmeet Kaur, Bhushan Madke, Ashish Dalal
2 [GO] 2021―Jul―14 Reduction in the number of early melanomas diagnosed during the COVID-19 pandemic: a single-center cohort study Erica Koch, Francisco Villanueva, Michael A. Marchetti, Álvaro Abarzúa, Consuelo Cárdenas, Juan Camilo Castro, et al. (+13)
3 [GO] 2021―Jul―09 Transition of cutaneous into systemic lupus erythematosus following adenoviral vector based SARS-CoV-2 vaccination Alexander Kreuter, Sven-Niklas Burmann, Björn Burckert, Frank Oellig, Alena-Lioba Michalowitz
4 [GO] 2021―Jul―09 “COVID arm” - histological features of a delayed type hypersensitivity reaction to Moderna mRNA-1273 SARS-CoV2 vaccine W. Kempf, N. Kettelhack, F. Kind, S. Courvoisier, J. Galambos, K. Pfaltz
5 [GO] 2021―Jul―08 Development of eruptive pseudoangiomatosis following COVID-19 immunization- apropos of 5 cases Alpana Mohta, Suresh Kumar Jain, Rajesh Dutt Mehta, Aakanksha Arora
6 [GO] 2021―Jul―08 Pityriasis rosea developing after COVID-19 vaccination O. Marcantonio-Santa Cruz, A. Vidal-Navarro, D. Pesqué, A.M. Giménez-Arnau, R.M. Pujol, G. Martin-Ezquerra
7 [GO] 2021―Jul―08 New-onset cutaneous lichen planus triggered by COVID-19 vaccination R. Merhy, A.S Sarkis, J. Kaikati, L. El Khoury, S. Ghosn, F. Stephan
8 [GO] 2021―Jul―08 Generalized eczematous reactions to the Pfizer-BioNTech COVID-19 vaccine AC Leasure, S Cowper, J McNiff, JM Cohen
9 [GO] 2021―Jul―08 Pernio-like skin lesions after the second dose of Pfizer-BioNTech COVID-19 vaccine N. Cameli, M. Silvestri, M. Mariano, S.P. Nisticò, A. Cristaudo
10 [GO] 2021―Jul―08 New onset of Remitting Seronegative Symmetrical Synovitis with Pitting Oedema and Palmoplantar Psoriasis flare-up after Sars-Cov-2 Vaccination L Quattrini, L Verardi, G Caldarola, G Peluso, C De Simone, M D’Agostino
11 [GO] 2021―Jul―08 Widespread purpura annularis telangiectodes following mRNA SARS-CoV-2 vaccine. D Falkenhain-López, C Gutiérrez-Collar, J Arroyo-Andrés, I Gallego-Gutiérrez, JL Rodríguez-Peralto, A Sánchez-Velázquez
12 [GO] 2021―Jun―25 The first dose of COVID-19 vaccine may trigger pemphigus and bullous pemphigoid flares: is the second dose therefore contraindicated? Giovanni Damiani, Alessia Pacifico, Francesco Pelloni, Matilde Iorizzo
13 [GO] 2021―Jun―25 Development of severe pemphigus vulgaris following SARS-CoV-2 vaccination with BNT162b2 Farzan Solimani, Yasmine Mansour, Dario Didona, Amrei Dilling, Kamran Ghoreschi, Katharina Meier
14 [GO] 2021―Jun―24 Delayed cutaneous reaction to ChAdOx1 nCoV-19 vaccine: Is it an ‘AstraZeneca arm’? Jeong Eun Kim, Hyun Lee, Seung Sam Paik, Ji-Yong Moon, Ho Joo Yoon, Sang-Heon Kim
15 [GO] 2021―Jun―19 Evolution of notified sexually transmitted infections in Barcelona during the First Wave of the COVID-19 Pandemic Gemma Martin-Ezquerra, Pablo Monreal, Lilas Mercuriali, Esperanza Cañas-Ruano, Ramon M Pujol, Xavier Duran, et al. (+28)
16 [GO] 2021―Jun―19 The Significance of Exanthems in COVID-19 Patients Hospitalized at a Tertiary Care Center Renajd Rrapi, Sidharth Chand, Jennifer A. Lo, Colleen K Gabel, Sarah Song, Zachary Holcomb, et al. (+9)
17 [GO] 2021―Jun―18 Describing the burden of the COVID-19 pandemic in people with psoriasis: findings from a global cross-sectional study SK Mahil, M Yates, ZZN Yiu, SM Langan, T Tsakok, N Dand, et al. (+31)
18 [GO] 2021―Jun―16 Psoriasis flare up associated with second dose of Pfizer-BioNTech BNT16B2b2 COVID-19 mRNA vaccine PK Krajewski, Ł Matusiak, JC Szepietowski
19 [GO] 2021―Jun―16 Chilblain-like lesions after BNT162b2 mRNA COVID-19 vaccine: a case report suggesting that ‘COVID toes’ are due to the immune reaction to SARS-CoV-2 C. Lesort, J. Kanitakis, L. Donzier, D. Jullien
20 [GO] 2021―Jun―16 A review of nail findings associated with COVID-19 infection Edward Hadeler, Brian W. Morrison, Antonella Tosti
21 [GO] 2021―Jun―16 Adverse Skin Reactions Due to Use of Face Masks: A Prospective Survey during the COVID-19 Pandemic in Korea S.J. Park, H.S. Han, S.H. Shin, K.H. Yoo, K. Li, B.J. Kim, et al. (+2)
22 [GO] 2021―Jun―03 Contemporary occurrence of Chilblain-like lesions and Pityriasis rosea during the COVID-19 pandemic Vincenzo Piccolo, Andrea Bassi, Giuseppe Argenziano, Carlo Mazzatenta, Mario Cutrone, Iria Neri, et al. (+2)
23 [GO] 2021―Jun―02 Patients with Primary Cutaneous Lymphoma are at risk for severe COVID-19. Data from the Spanish Primary Cutaneous Lymphoma Registry A. Sánchez-Velázquez, A. Bauer-Alonso, T. Estrach, D. Vega-Díez, P. Garcia-Muret, L. Haya, et al. (+26)
24 [GO] 2021―Jun―02 Immune thrombocytopenic purpura associated with COVID-19 Pfizer-BioNTech BNT16B2b2 mRNA vaccine PK Krajewski, JC Szepietowski
25 [GO] 2021―May―31 Ipsilateral Herpes Zoster after the first dose of BNT162b2 mRNA COVID-19 vaccine Ioannis Tessas, Nicolas Kluger
26 [GO] 2021―May―31 Acute postinfectious Pityriasis Rubra Pilaris as a cutaneous manifestation in COVID-19: a case report and its dermoscopic features. D. Kadylak, W. Barańska-Rybak
27 [GO] 2021―May―28 Purpuric lesions on the eyelids developed after BNT162b2 mRNA COVID-19 vaccine: another piece of SARS-CoV-2 skin puzzle? C. Mazzatenta, V. Piccolo, G. Pace, I. Romano, G. Argenziano, A. Bassi
28 [GO] 2021―May―26 Frequency of relapse and persistent cutaneous symptoms after a first episode of chilblain-like lesion during the COVID-19 pandemic Parna Moghadam, Laure Frumholtz, Léa Jaume, Adèle De Masson, Marie Jachiet, Edouard Begon, et al. (+6)
29 [GO] 2021―May―26 Dapsone induced methemoglobinemia in leprosy: A close mimic of ‘happy hypoxia’ in the COVID-19 pandemic Tanu Tripathi, Anchit Raj Singh, Rajan Kapoor, Anwita Sinha, Saikat Ghosh, Kanwaljit Kaur, et al. (+4)
30 [GO] 2021―May―26 SARS-CoV-2 mRNA Vaccine-Associated Fixed Drug Eruption Dillon Mintoff, David Pisani, Alexandra Betts, Lawrence Scerri
31 [GO] 2021―May―25 Urticarial Vasculitis revealing immunolabelled nucleocapsid protein of SARS-CoV-2 in two Brazilian asymptomatic patients: the tip of the COVID-19 hidden iceberg? Paulo Ricardo Criado, Roberta Fachini Jardim Criado, Raffaele Gianotti, Beatrice Artinez Zugaib Abdalla, Thais Prota Hussein Pincelli, Alexandre Osores Michalany, Nilceo Schwery Michalany
32 [GO] 2021―May―22 Cutaneous adverse reactions after m-RNA COVID-19 vaccine: early reports from North-East Italy E. Farinazzo, G. Ponis, E. Zelin, E. Errichetti, G. Stinco, C. Pinzani, et al. (+9)
33 [GO] 2021―May―20 Detection of a second outbreak of chilblain-like lesions during COVID-19 pandemic through teledermatology Laura Giraud-Kerleroux, Margaux Mongereau, Charles Cassius, Marc Mrad, Charlotte Gary, Caroline Fiani, et al. (+9)
34 [GO] 2021―May―20 Not all that glitters is COVID-19: a case-series demonstrating the need for histopathology when skin findings accompany SARS-CoV-2 infection A Barrera-Godínez, S Méndez-Flores, M Gatica-Torres, A Rosales-Sotomayor, KI Campos-Jiménez, DM Carrillo-Córdova, et al. (+8)
35 [GO] 2021―May―20 SARS-CoV-2: skin diseases, mask wearing and unpleasant sensations B Cribier, C Taieb, M Saint Aroman, J Shourick
36 [GO] 2021―May―14 Heterogeneous red-white discoloration of the nail bed and distal onycholysis in a patient with COVID-19 Betul Demir, Esma Inan Yuksel, Demet Cicek, Sedatcan Turkoglu
37 [GO] 2021―May―13 Androgenetic alopecia in women and men is not related to COVID-19 infection severity: A prospective cohort study of hospitalized COVID-19 patients Shatila Torabi, Mahnaz Mozdourian, Roxana Rezazadeh, Abolfazl Payandeh, Shapour Badiee, Emadodin Darchini-Maragheh
38 [GO] 2021―May―13 Recurrent injection-site reactions after incorrect subcutaneous administration of a COVID-19 vaccine M Gyldenløve, L Skov, CB Hansen, P Garred
39 [GO] 2021―May―13 Pityriasis rosea-like eruptions following vaccination with BNT162b2 mRNA COVID-19 Vaccine Benoit Cyrenne, Faisal Al-Mohammedi, Joel DeKoven, Raed Alhusayen
40 [GO] 2021―Apr―29 Adamantiades-Behçet’s disease (Behçet’s disease) and COVID-19 C.C. Zouboulis, J.A.M. Laar, M. Schirmer, G. Emmi, F. Fortune, A. Gül, et al. (+5)
41 [GO] 2021―Apr―29 Non-acral skin manifestations during the COVID-19 epidemic: COVIDSKIN study by the French Society of Dermatology R Guelimi, R Salle, L Dousset, H Assier, S Fourati, Z Bhujoo, et al. (+18)
42 [GO] 2021―Apr―29 Pityriasis rosea following CoronaVac COVID-19 vaccination: a case report Elçin Akdaş, Nilsel İlter, Betül Öğüt, Özlem Erdem
43 [GO] 2021―Apr―29 BNT162b2 mRNA Covid-19 Vaccine-induced chilblain-like lesions reinforces the hypothesis of their relationship with SARS-CoV-2 Vincenzo Piccolo, Andrea Bassi, Giuseppe Argenziano, Carlo Mazzatenta, Mario Cutrone, Iria Neri, et al. (+2)
44 [GO] 2021―Apr―26 “Pityriasis rosea, COVID-19 and vaccination: new keys to understand an old acquaintance” JM Busto-Leis, G Servera-Negre, A Mayor-Ibarguren, E Sendagorta-Cudós, M Feito-Rodríguez, A Nuño-González, et al. (+2)
45 [GO] 2021―Apr―20 Incidence and prognosis of COVID-19 in psoriasis patients on biologic therapy: a multicenter retrospective cohort study Jorge R. Georgakopoulos, Asfandyar Mufti, Ron Vender, Vimal H. Prajapati, Jensen Yeung
46 [GO] 2021―Apr―19 Covid-19-triggered sarcoidal granulomas mimicking scar sarcoidosis A Polat Ekinci, N Büyükbabani, S Meşe, G Pehlivan, NG Okumuş, A Ağaçfidan, E Özkaya
47 [GO] 2021―Apr―19 Recurrence of previous chilblain lesions during the second wave of COVID-19: can we still doubt the correlation with SARS-CoV-2? S Signa, AR Sementa, MC Coccia, C Pastorino, G Viglizzo, S Viola, et al. (+7)
48 [GO] 2021―Apr―18 Adverse skin reactions related to PPE among health care workers managing COVID-19 Priyanka Sharma, Nainika Goel, Kanika Dogar, Mala Bhalla, GP Thami, Kavita Punia
49 [GO] 2021―Apr―18 Under-representation of people of African ancestry in publications on the cutaneous manifestations of COVID-19: coincidence or physiology? C Cassius, L Frumholtz, A de Masson, O Dadzie, A Petit
50 [GO] 2021―Apr―18 Penile ischemia secondary to COVID-19: Why should the dermatologist be concerned? P. Sarkis, J. Sarkis, M. Alkassis, J. Assaf, K. El Gharib
51 [GO] 2021―Apr―09 Good tolerance of hyaluronic acid injections during the period of the Covid-19 pandemic: observing a cohort of 1093 patients in a prospective, observational real-life study Michael Naouri, Serge Dahan, Anne Le Pillouer Prost, Phrynée Coutant-Foulc, Catherine Raimbault, Françoise Cucurella, et al. (+10)
52 [GO] 2021―Apr―09 Transient cutaneous manifestations after administration of Pfizer-BioNTech COVID-19 Vaccine: an Italian single centre case series M. Corbeddu, A. Diociaiuti, MR. Vinci, A. Santoro, V. Camisa, S. Zaffina, M. El Hachem
53 [GO] 2021―Apr―08 Nail changes as manifestation of systemic disease in COVID-19 infection SS Ocampo-Garza, J Ocampo-Candiani, E Camela, M Vastarella, G Fabbrocini, M Scalvenzi, A Villani
54 [GO] 2021―Mar―30 Extraordinary Claims Without Extraordinary Evidence Controversy on Anti-Androgen Therapy for COVID-19 R.M. Trüeb, A. Régnier, N. Caballero-Uribe, M.F. Reis Gavazzoni Dias, H. Dutra Rezende
55 [GO] 2021―Mar―30 Persistent maculopapular rash after the first dose of Pfizer-BioNTech COVID-19 vaccine. M Ackerman, D Henry, A Finon, R Binois, E Esteve
56 [GO] 2021―Mar―30 Skin manifestations of the BNT162b2 mRNA COVID-19 vaccine in healthcare workers. “COVID-arm”: a clinical and histological characterization D. Fernandez-Nieto, J. Hammerle, M. Fernandez-Escribano, CM Moreno-del Real, P. Garcia-Abellas, I. Carretero-Barrio, et al. (+5)
57 [GO] 2021―Mar―29 Position statement of the EADV Melanoma Task Force on recommendations for the management of cutaneous melanoma patients during COVID-19 M. Arenbergerova, A. Lallas, E. Nagore, L. Rudnicka, A. Forsea, M. Pasek, et al. (+4)
58 [GO] 2021―Mar―29 A new virtual inpatient dermatology electronic referral service: a timely solution in the COVID-19 pandemic and beyond? A Lowe, A Pararajasingam, FM Ali, S Dawood, CD Lowe, NM Stone
59 [GO] 2021―Mar―29 VACCINATION AGAINST SARS-COV-2 and PSORIASIS: the three things every dermatologist should know F. Diotallevi, A. Campanati, G. Radi, E. Martina, G. Rizzetto, P Barbadoro, et al. (+2)
60 [GO] 2021―Mar―22 Risk of severe allergic reactions to COVID-19 vaccines among patients with allergic skin diseases - practical recommendations. A position statement of ETFAD with external experts J Ring, M Worm, A Wollenberg, JP Thyssen, T Jakob, L Klimek, et al. (+30)
61 [GO] 2021―Mar―17 Follow-up of dermatological manifestations in non-critical hospitalized patients with COVID-19 pneumonia and their prognostic correlation with disease severity A García-Irigoyen, GA Acatitla-Acevedo, A Barrera-Godínez, S Méndez-Flores, J Domínguez-Cherit
62 [GO] 2021―Mar―16 COVID-19 pandemic and autoimmune bullous diseases: A cross-sectional study of the International Pemphigus and Pemphigoid Foundation M. Kasperkiewicz, M. Yale, R. Strong, D. Zillikens, D.T. Woodley, A. Recke
63 [GO] 2021―Mar―16 Periocular capillaritis in a COVID-19 positive patient: report of a case A Paganelli, F Garbarino, L Bigi
64 [GO] 2021―Mar―16 Lichen planus arising after COVID-19 vaccination I. Hiltun, J. Sarriugarte, I. Martínez-de-Espronceda, A. Garcés, C. Llanos, R. Vives, J.I. Yanguas
65 [GO] 2021―Mar―16 Prompt onset of erythema multiforme following the first BNT162b2 SARS-CoV-2 vaccination T. Gambichler, L. Scholl, L. Ocker, R. Stranzenbach
66 [GO] 2021―Mar―03 Updated international expert recommendations for the management of autoimmune bullous diseases during the COVID-19 pandemic M. Kasperkiewicz, E. Schmidt, M. Amagai, J.A. Fairley, P. Joly, D.F. Murrell, et al. (+4)
67 [GO] 2021―Mar―02 Association Between COVID-19 and Chilblains: A Case-Control Study Daniel Ortega-Quijano, Diego Fernandez-Nieto, Juan Jimenez-Cauhe, Jose Luis Cortes-Cuevas, Daniel Marcos-Mencia, Mario Rodriguez-Dominguez, et al. (+3)
68 [GO] 2021―Mar―02 Insights into COVID-19 vaccination in patients with chronic plaque psoriasis on systemic treatments P Gisondi, D Geat, L Naldi, S Piaserico
69 [GO] 2021―Mar―02 Chilblains in a child with confirmed SARS-CoV-2 infection: a red flag for late onset skin manifestation in previously infected individuals Iria Neri, Francesca Conti, Annalucia Virdi, Alba Guglielmo, Lucia Leonardi, Ilaria Corsini, et al. (+6)
70 [GO] 2021―Feb―18 European Task Force on Atopic Dermatitis (ETFAD): position on vaccination of adult patients with atopic dermatitis against COVID-19 (SARS-CoV-2) being treated with systemic medication and biologics Jacob P. Thyssen, Christian Vestergaard, Sebastien Barbarot, Marjolein S. de Bruin-Weller, Thomas Bieber, Alain Taieb, et al. (+29)
71 [GO] 2021―Feb―15 Relapse of chilblain-like lesions during the second wave of COVID-19 S. Recalcati, T. Barbagallo, S. Tonolo, M. Milani, F. Fantini
72 [GO] 2021―Feb―15 COVID-19 and immune checkpoint inhibitors M.S. Ahmed, H. Brehme, S. Friedrich, L. Reinhardt, S. Blum, S. Beissert, F. Meier
73 [GO] 2021―Feb―15 An Irish Department of Genito-Urinary Medicine in the COVID-19 Era D. Moriarty, C O’Connor, J. Bourke, M Murphy, M. Horgan, S Cremin
74 [GO] 2021―Feb―15 Concerns and perceptions of patients with psoriatic disease during the COVID-19 pandemic: results from a two-wave survey by the National Psoriasis Foundation G.C. Gondo, S.J. Bell, J. Slayden, G. Ullmann, A. Blauvelt
75 [GO] 2021―Feb―15 Rapidly progressive alopecia areata totalis in a Covid-19 patient, unresponsive to tofacitinib S. Berbert Ferreira, M.F.R. Gavazzoni Dias, R. Berbert Ferreira, A.C. Neves Neto, R.M. Trüeb, O. Lupi
76 [GO] 2021―Feb―15 Is SARS-CoV-2 screening test indicated for psoriasis patients candidate to biologic therapy? S. Piaserico, P. Gisondi, S. Cazzaniga, G. Girolomoni, PG. Calzavara-Pinton, L. Naldi
77 [GO] 2021―Feb―06 Absence of SARS-CoV-2 RNA detection in tissue samples of COVID-19-related cutaneous lesions analyzed by real-time RT-PCR MF García-Gil, J Monte-Serrano, M García García, Lucia Prieto-Torres, AJ Pascual-del-Riquelme, I Casas Flecha, M Ara-Martín
78 [GO] 2021―Feb―06 Chilblain-like lesions and COVID-19: second wave, second outbreak Vincenzo Piccolo, Andrea Bassi, Teresa Russo, Carlo Mazzatenta, Maura Baraldi, Giuseppe Argenziano, et al. (+2)
79 [GO] 2021―Feb―06 Position statement for a pragmatic approach to immunotherapeutics in patients with inflammatory skin diseases during the coronavirus disease 2019 pandemic and beyond J. Beecker, K.A. Papp, J. Dutz, R.B. Vender, R. Gniadecki, C. Cooper, et al. (+8)
80 [GO] 2021―Jan―18 COVID-19 and HHV8 first spotted together: an affair under electron microscopy E. Leoni, M. Cerati, G. Finzi, M. Lombardo, F. Sessa
81 [GO] 2021―Jan―15 Dermato-venereology in the year of coronavirus - Hot topics in research and patient care J. Ring
82 [GO] 2020―Dec―23 COVID-19 has changed our society as well as Dermatology J. Ring
83 [GO] 2020―Dec―23 Corrigendum: Management of primary cutaneous lymphoma patients during COVID-19 pandemic: EORTC CLTF guidelines E. Papadavid, J. Scaribrick, P. Ortiz Romero, P. Quaglino, M. Vermeer, R. Knobler, et al. (+2)
84 [GO] 2020―Dec―18 Understanding Views of Patients on Biologics for Psoriasis Amid the COVID-19 Pandemic Karan Pandher, Caroline L. Porter, Hiral S. Patel, William W. Huang, Steven R. Feldman
85 [GO] 2020―Dec―09 Palmoplantar erythrodysestesia: a diagnostic sign of COVID-19 Almudena Nuno-Gonzalez, Kyrylo Magaletsky, Marta Feito Rodríguez, Ander Mayor Ibarguren, Maria Jose Beato, Elena Ruiz Bravo, Pedro Herranz Pinto
86 [GO] 2020―Dec―01 Lack of skin manifestations in COVID-19 hospitalized patients during the second epidemic wave in Spain: a possible association with a novel SARS-CoV-2 variant. A cross-sectional study. D. Fernandez-Nieto, D. Ortega-Quijano, A. Suarez-Valle, J. Jimenez-Cauhe, P. Jaen-Olasolo, M. Fernandez-Guarino
87 [GO] 2020―Dec―01 Pityriasis rosea as a leading manifestation of COVID-19 infection R. Merhy, A.S Sarkis, F. Stephan
88 [GO] 2020―Nov―21 Adverse skin reactions following different types of mask usage during the COVID-19 pandemic Chayada Chaiyabutr, Thanisorn Sukakul, Chutipon Pruksaeakanan, Janista Thumrongtharadol Waranya Boonchai
89 [GO] 2020―Nov―21 Impact of the COVID-19 Pandemic on Inpatient Dermatology: A Multicenter Study from Hubei, China Yamin Zhang, Jingjing Wen, Mahin Alamgir, Jun Xie, Haixia Jing, Muping Fang, et al. (+5)
90 [GO] 2020―Nov―21 SARS-CoV-2-induced telogen effluvium: a multicentric study O.M. Moreno-Arrones, A. Lobato-Berezo, A. Gomez-Zubiaur, S. Arias-Santiago, D. Saceda-Corralo, C. Bernardez-Guerra, et al. (+9)
91 [GO] 2020―Nov―02 Self-reported cutaneous manifestations in 1,429 Brazilian COVID-19 patients Hélio Amante Miot, Mayra Ianhez, Paulo Müller Ramos
92 [GO] 2020―Nov―02 5-Alpha-Reductase Inhibitors are Associated with Reduced Frequency of COVID-19 Symptoms in Males with Androgenetic Alopecia John McCoy, Flávio Adsuara Cadegiani, Carlos Gustavo Wambier, Sabina Herrera, Sergio Vaño-Galván, Natasha Atanaskova Mesinkovska, et al. (+5)
93 [GO] 2020―Nov―01 COVID-19 in patients with cutaneous immune-mediated diseases in The Netherlands: real-world observational data L.E.M. de Wijs, M.M. Joustra, J.I. Olydam, T. Nijsten, D.J. Hijnen
94 [GO] 2020―Oct―22 Clinical Symptoms of Hyperandrogenic Women Diagnosed with COVID-19 FA Cadegiani, RK Lim, A Goren, J McCoy, M Situm, M Kovacevic, et al. (+4)
95 [GO] 2020―Oct―22 Are SARS-CoV-2 IgA antibodies in paediatric patients with chilblain-like lesions indicative of COVID-19 asymptomatic or paucisymptomatic infection? A. Diociaiuti, S. Giancristoforo, S. Terreri, M. Corbeddu, C. Concato, M. Ciofi Degli Atti, et al. (+3)
96 [GO] 2020―Oct―20 A multicenter study on effectiveness and safety of risankizumab in psoriasis: an Italian 16-week real-life experience during the COVID-19 pandemic K. Hansel, A. Zangrilli, L. Bianchi, K. Peris, A. Chiricozzi, A. Offidani, et al. (+7)
97 [GO] 2020―Oct―20 Increase in sexually transmitted infection during the COVID-19 pandemic in Taiwan Kun-Kuang Lee, Chih-Cheng Lai, Chien-Ming Chao, Hung-Jen Tang
98 [GO] 2020―Oct―12 Diagnosis of hair disorders during the COVID-19 pandemic: An introduction to teletrichoscopy M. Randolph, A. Al-alola, A. Tosti
99 [GO] 2020―Oct―03 Why are chilblains underreported in Nordic countries during the COVID-19 pandemic? An analysis of Google trends Nicolas Kluger
100 [GO] 2020―Oct―03 Immunological and virological profile of children with chilblain-like lesions and SARS-CoV-2 L. Fertitta, A. Welfringer, A. Ouedrani, L. Polivka, S. Chhun, L. Chatenoud, et al. (+5)
101 [GO] 2020―Oct―01 SARS-CoV-2 spike protein is present in both endothelial and eccrine cells of a chilblain-like skin lesion T. Gambichler, J. Reuther, M. Stücker, R. Stranzenbach, C. Torres-Reyes, R. Schlottmann, et al. (+4)
102 [GO] 2020―Sep―27 “Occupational dermatoses from Personal Protective Equipment during the COVID-19 pandemic in the tropics - A Review” HC Lee, CL Goh
103 [GO] 2020―Sep―26 Anti-androgens may protect against severe COVID-19 outcomes: results from a prospective cohort study of 77 hospitalized men Andy Goren, Carlos Gustavo Wambier, Sabina Herrera, John McCoy, Sergio Vaño-Galván, Francesca Gioia, et al. (+9)
104 [GO] 2020―Sep―25 Androgen Receptor Genetic Variant Predicts COVID-19 Disease Severity: A Prospective Longitudinal Study of Hospitalized COVID-19 Male Patients John McCoy, Carlos Gustavo Wambier, Sabina Herrera, Sergio Vaño-Galván, Francesca Gioia, Belen Comeche, et al. (+9)
105 [GO] 2020―Sep―24 Comment on “Drug reaction with eosinophilia and systemic symptoms syndrome in a patient with COVID-19”: Involvement of herpesvirus reactivations and adverse drug reactions in diverse cutaneous manifestations and overall disease severity of COVID-19 Tetsuo Shiohara, Yoshiko Mizukawa
106 [GO] 2020―Sep―01 Cutaneous Symptoms of Patients Diagnosed with Covid-19 in One Province: A Cross-Sectional Survey Eda Öksüm Solak, Burcu Baran Ketencioglu, Hümeyra Aslaner, Salih Levent Çinar, Demet Kartal, Ali Ramazan Benli, Murat Borlu
107 [GO] 2020―Sep―01 Frequent hand washing and disinfection-a potential new trigger for aquagenic wrinkling of the palms caused by COVID-19 outbreak Yukimasa Tai, Takeshi Fukumoto, Masahiro Oka, Chikako Nishigori
108 [GO] 2020―Sep―01 How the use of surgical masks during COVID-19 pandemic can induce skin effects S. Veronese, P. Bernardi, A. Sbarbati
109 [GO] 2020―Sep―01 Generalized Pustular Figurate Erythema. First Report in Two COVID-19 Patients on Hydroxychloroquine I. Abadías-Granado, A.M. Palma-Ruiz, P.A. Cerro, A.M. Morales-Callaghan, M.C. Gómez-Mateo, Y. Gilaberte, R.A. Schwartz
110 [GO] 2020―Sep―01 Skin manifestations in COVID-19 provide a clue for disease’s pathophysiology understanding AA Kubanov, DG Deryabin
111 [GO] 2020―Aug―31 Chilblains and COVID-19: further evidence against a causal association Marie Baeck, Caroline Peeters, Anne Herman
112 [GO] 2020―Aug―27 Toxic epidermal necrolysis and co-existent SARS-CoV-2 (COVID-19) treated with Intravenous Immunoglobulin: “ Killing 2 birds with one ston e” M. Saha, A. D’Cruz, N. Paul, R. Healy, D. Collins, D-A. Charles, et al. (+2)
113 [GO] 2020―Aug―27 COVID-19-related cutaneous manifestations associated with multiple drug sensitization as shown by lymphocyte transformation test Jun Hayakawa, Hiroki Takakura, Yoshiko Mizukawa, Tetsuo Shiohara
114 [GO] 2020―Aug―27 Scabies outbreak during home confinement due to the SARS-CoV-2 pandemic Isabel Martínez-Pallás, Beatriz Aldea-Manrique, Mar Ramírez-Lluch, José Manuel Vinuesa-Hernando, Mariano Ara-Martín
115 [GO] 2020―Aug―27 Acral skin eruption observed during SARS-CoV-2 pandemic: possible keratolysis exfoliativa with red palms and soles Iria Neri, Annalisa Patrizi, Liliana Gabrielli, Annalucia Virdi, Giulia Veronesi, Ilaria Corsini, et al. (+4)
116 [GO] 2020―Aug―13 Recommendations for skin cancer consultation and surgery during COVID-19 pandemic L. Brochez, J.F. Baurain, V. Del Marmol, A. Nikkels, V. Kruse, F. Sales, et al. (+3)
117 [GO] 2020―Aug―12 Delayed melanoma diagnosis in the COVID-19 era: Increased breslow thickness in primary melanomas seen after the COVID-19 lockdown F. Ricci, L. Fania, A. Paradisi, G. Di Lella, S. Pallotta, L. Sobrino, et al. (+3)
118 [GO] 2020―Aug―12 Severe COVID-19 outcomes in patients with psoriasis X.T. Lima, M.A. Cueva, E.M Lopes, M.B. Alora
119 [GO] 2020―Aug―12 Concerns related to the COVID-19 pandemic in adult patients with atopic dermatitis and psoriasis treated with systemic immunomodulatory therapy: a Danish questionnaire survey Nikolai Dyrberg Loft, Anne-Sofie Halling, Lars Iversen, Christian Vestergaard, Mette Deleuran, Mads Kirchheiner Rasmussen, et al. (+3)
120 [GO] 2020―Aug―03 A survey on teledermatology (td) use and doctors’ perception in times of COVID-19 Elvira Moscarella, Paola Pasquali, Elisa Cinotti, Linda Tognetti, Giuseppe Argenziano, Pietro Rubegni
121 [GO] 2020―Jul―31 Drug reaction with eosinophilia and systemic symptoms syndrome in a patient with COVID-19 Anne Herman, Marine Matthews, Margaux Mairlot, Laura Nobile, Laetiia Fameree, Luc-Marie Jacquet, Marie Baeck
122 [GO] 2020―Jul―31 Management of biological therapies for chronic plaque psoriasis during COVID-19 emergency in Italy M Talamonti, M Galluzzo, A Chiricozzi, P Quaglino, G Fabbrocini, P Gisondi, et al. (+64)
123 [GO] 2020―Jul―17 The skin in the era of coronavirus pandemic J. Ring
124 [GO] 2020―Jul―11 STIs and the COVID-19 pandemic: the lockdown does not stop sexual infections R. Balestri, M. Magnano, L. Rizzoli, S.D. Infusino, F. Urbani, G. Rech
125 [GO] 2020―Jul―03 Concurrent chilblains and retinal vasculitis in a child with COVID-19 Lucía Quintana-Castanedo, Marta Feito-Rodríguez, Celia Fernández-Alcalde, María Granados-Fernández, Dolores Montero-Vega, Ander Mayor-Ibarguren, Raúl de Lucas-Laguna
126 [GO] 2020―Jul―03 Dermoscopy features of COVID-19-related chilblains in children and adolescents Lourdes Navarro, David Andina, Lucero Noguera-Morel, Angela Hernández-Martín, Isabel Colmenero, Antonio Torrelo
127 [GO] 2020―Jun―28 COVID-19 and cutaneous manifestations: A systematic review Qing Zhao, Xiaokai Fang, Zheng Pang, Bowen Zhang, Hong Liu, Furen Zhang
128 [GO] 2020―Jun―28 COVID-19 and outbreak of chilblains: are they related? C. Lesort, J. Kanitakis, A. Villani, E. Ducroux, P. Bouschon, K. Fattouh, et al. (+3)
129 [GO] 2020―Jun―28 Prior treatment with immunosuppressants among COVID-19 inpatients at one hospital in Spain MA Pastor-Nieto, P Checa-Díaz, P González-Muñoz, A Martín-Fuentes, A Vergara-Sánchez, C Sánchez-Herreros, et al. (+8)
130 [GO] 2020―Jun―28 COVID-19 Lockdown induced acral dermatosis in children Nathalie Bodak, Christine Chiaverini, Sebastien Barbarot
131 [GO] 2020―Jun―28 Compliance, safety concerns and anxiety in patients treated with biologics for psoriasis during the COVID-19 pandemic national lockdown: A multicenter study in the Czech Republic F Rob, J Hugo, S Tivadar, P Boháč, S Gkalpakiotis, N Vargová, et al. (+2)
132 [GO] 2020―Jun―27 Cutaneous manifestations in SARS-CoV-2 infection (COVID-19): a French experience and a systematic review of the literature S. Matar, B. Oulès, P. Sohier, O. Chosidow, M. Beylot-Barry, N. Dupin, S. Aractingi
133 [GO] 2020―Jun―27 Acute acral cutaneous manifestations during the COVID-19 pandemic: a single center experience Marta García-Legaz Martínez, Álvaro Martínez-Doménech, Jorge Magdaleno-Tapial, Cristian Valenzuela-Oñate, Felipe Partarrieu-Mejías, Javier Lorca-Spröhnle, et al. (+3)
134 [GO] 2020―Jun―27 Recent outbreak of chilblain-like lesions is not directly related with SARS-CoV-2 infection J. Rouanet, E. Lang, F. Beltzung, B. Evrard, C. Henquell, I. Joulie, M. D’Incan
135 [GO] 2020―Jun―26 Relapsing symmetric livedo reticularis in a patient with COVID-19 infection M. Verheyden, M. Grosber, J. Gutermuth, B. Velkeniers
136 [GO] 2020―Jun―25 Cutaneous manifestations of SARS-CoV-2 infection: a clinical update P Gisondi, S PIaserico, C Bordin, M Alaibac, G Girolomoni, L Naldi
137 [GO] 2020―Jun―21 Systemic or biologic treatment in psoriasis patients does not increase the risk of a severe form of COVID-19 Anne-Claire Fougerousse, Marc Perrussel, Pierre-André Bécherel, Edouard Begon, Valérie Pallure, Ines Zaraa, et al. (+8)
138 [GO] 2020―Jun―19 ‘’Treatment adherence in psoriatic patients during COVID-19 pandemic: Real-world data from a tertiary hospital in Greece’’ Authors: E Vakirlis, K Bakirtzi, I Papadimitriou, F Vrani, N Sideris, A Lallas, et al. (+2)
139 [GO] 2020―Jun―19 An unusual case of bullous hemorrhagic vasculitis in a COVID-19 patient S. Negrini, A. Guadagno, M. Greco, A. Parodi, M. Burlando
140 [GO] 2020―Jun―18 Catastrophic acute bilateral lower limbs necrosis associated with COVID-19 as a likely consequence of both vasculitis and coagulopathy P Del Giudice, D Boudoumi, B Le Guen, M Reverte, J Gutnecht, JP Lacour, et al. (+3)
141 [GO] 2020―Jun―18 Cutaneous involvement during COVID-19 pandemic: an emerging sign of infection Maria Carmela Annunziata, Angela Patrì, Angelo Ruggiero, Adriana Di Guida, Claudia Menicanti, Vincenzo Greco, Gabriella Fabbrocini
142 [GO] 2020―Jun―16 Symmetric chest pressure ulcers, consequence of prone position ventilation in a patient with COVID-19 N Martínez Campayo, JI Bugallo Sanz, I Mosquera Fajardo
143 [GO] 2020―Jun―14 Occupational skin disease during the COVID-19 pandemic, as captured in a Dermatology staff clinic in the United Kingdom Sofia Hadjieconomou, Jenny Hughes, Sandeep Kamath
144 [GO] 2020―Jun―14 The red half moon nail sign: a novel manifestation of Coronavirus infection Iria Neri, Alba Guglielmo, Annalucia Virdi, Valeria Gaspari, Michela Starace, Bianca Maria Piraccini
145 [GO] 2020―Jun―14 SARS-CoV-2, skin lesions and the need of a multidisciplinary approach R. Cabrera-Hernández, E. Solano-Solares, V. Chica-Guzmán, M. Fernández-Guarino, D. Fernández-Nieto, D. Ortega-Quijano, et al. (+6)
146 [GO] 2020―Jun―13 Major cluster of pediatric “ true ” primary chilblains during the COVID-19 pandemic: a consequence of lifestyle changes due to lockdown Neri Iria, Virdi Annalucia, Corsini Ilaria, Guglielmo Alba, Lazzarotto Tiziana, Gabrielli Liliana, et al. (+3)
147 [GO] 2020―Jun―13 Cutaneous manifestations of hospitalized COVID-19 patients: A report of six cases with clinicopathologic features and viral RNA in situ hybridization C. Bitar, M.P. Chan, P.W. Harms, D.R. Fullen, J.E. Gudjonsson, M. Eshaq, et al. (+7)
148 [GO] 2020―Jun―13 Teledermatology for acne during COVID-19: high patients’ satisfaction in spite of the emergency Angelo Ruggiero, Matteo Megna, Maria Carmela Annunziata, Luisa Abategiovanni, Massimiliano Scalvenzi, Andrea Tajani, et al. (+2)
149 [GO] 2020―Jun―13 Cutaneous autoimmune diseases during COVID 19 pandemic C Günther, R Aschoff, S Beissert
150 [GO] 2020―Jun―12 A generalized purpuric eruption with histopathologic features of leucocytoclastic vasculitis in a patient severely ill with COVID-19 V. Caputo, J. Schroeder, F. Rongioletti
151 [GO] 2020―Jun―12 Two cases of cutaneous eruptions due to CoVID-19 infection in Singapore: New insights into the spectrum of clinical presentation and histopathology Benjamin Wen Yang Ho, Dingyuan Wang, Llewelyn Yi Chang Tan, Manish Mahadeorao Bundele, Chee Hian Tan, Joel Hua-Liang Lim
152 [GO] 2020―Jun―12 Papular-Purpuric Exanthem in a COVID-19 Patient: Clinical and Dermoscopic Description J. Larrondo, R. Cabrera, M. Gosch, F. Larrondo, M. Aylwin, A. Castro
153 [GO] 2020―Jun―11 The broad spectrum of dermatological manifestations in COVID-19. Clinical and histopathological features learned from a series of 34 cases C.A. Rubio-Muniz, M. Puerta-Peña, D. Falkenhain-López, J. Arroyo-Andrés, M. Agud-Dios, J.L. Rodriguez-Peralto, et al. (+2)
154 [GO] 2020―Jun―11 SARS-CoV, Mers-CoV and Covid-19:what differences from a dermatological viewpoint? Franco Rongioletti
155 [GO] 2020―Jun―08 Urticarial vasculitis in COVID-19 infection: a vasculopathy-related symptom? D. de Perosanz-Lobo, D. Fernandez-Nieto, P. Burgos-Blasco, G. Selda-Enriquez, I. Carretero, C. Moreno, M. Fernández-Guarino
156 [GO] 2020―Jun―05 Histology of skin lesions establishes that the vesicular rash associated with COVID-19 is not “varicella-like” A. Mahé, E. Birckel, C. Merklen, P. Lefèbvre, C. Hannedouche, M. Jost, L. Droy-Dupré
157 [GO] 2020―Jun―04 Position statement of the European Academy of Dermatology and Venereology Task Force on Quality of Life and Patient Oriented Outcomes on quality of life issues in dermatologic patients during the COVID-19 pandemic PV Chernyshov, L Tomas-Aragones, M Augustin, A Svensson, A Bewley, F Poot, et al. (+14)
158 [GO] 2020―Jun―04 Exanthema and eosinophilia in Covid-19 patients: has viral infection a role in drug induced exanthemas? AM Rosell-Díaz, A Mateos-Mayo, LM Nieto-Benito, I Balaguer-Franch, E Hernández de, A Laínez-Nuez, et al. (+2)
159 [GO] 2020―Jun―04 Eosinophilic granulomatosis with polyangiitis mimicking COVID-19: a case report H. Hashizume, Y. Sano, S. Furukawa, S. Imokawa
160 [GO] 2020―Jun―04 Iatrogenic dermatitis in times of COVID-19: A pandemic within a pandemic Riti Bhatia, Tekumalla Sindhuja, Saurabh Bhatia, Tanvi Dev, Atula Gupta, Meenu Bajpai, Somesh Gupta
161 [GO] 2020―Jun―04 Clinical and histological characterization of late appearance maculopapular eruptions in association with the coronavirus disease 2019. A case series of seven patients. A Reymundo, A Fernáldez-Bernáldez, A Reolid, B Butrón, P Fernández-Rico, P Muñoz-Hernández, et al. (+2)
162 [GO] 2020―Jun―03 No antibody response in acral cutaneous manifestations associated with COVID-19 ? Rafael Mahieu, Lila Tillard, Hélène Le Guillou-Guillemette, Emeline Vinatier, Pascale Jeannin, Anne Croué, et al. (+2)
163 [GO] 2020―Jun―03 Retiform purpura as a dermatological sign of covid-19 coagulopathy X Bosch-Amate, P Giavedoni, S Podlipnik, C Andreu-Febrer, J Sanz-Beltran, A Garcia-Herrera, et al. (+2)
164 [GO] 2020―Jun―03 Pitfalls of possible reporting of same patients with COVID-19 in dermatology journals Nicolas Kluger
165 [GO] 2020―Jun―03 Acro-ischemia and COVID-19 infection: clinical and histopathological features J Calvão, M Relvas, A Pinho, A Brinca, J.C. Cardoso
166 [GO] 2020―Jun―03 Sexually Transmitted Infections during the COVID-19 outbreak: comparison of patients referring to the service of sexually transmitted diseases during the sanitary emergency with those referring during the common practice L. Sacchelli, F. Viviani, G. Orioni, P. Rucci, S. Rosa, A. Lanzoni, et al. (+2)
167 [GO] 2020―Jun―03 COVID-19: how it can look on the skin. Clinical and pathological features in twenty COVID-19 patients observed in Bologna, northeastern Italy Valeria Gaspari, Iria Neri, Cosimo Misciali, Annalisa Patrizi
168 [GO] 2020―Jun―03 Hand Eczema Pandemic Caused by SARS-CoV-2 Hygiene Measures: The Setup of a Hand Eczema Helpline for Hospital Personnel K. Greveling, A.C.M. Kunkeler
169 [GO] 2020―Jun―03 Retroauricular dermatitis with vehement use of ear loop face masks during COVID19 pandemic Atul Bothra, Seujee Das, Mehak Singh, Manoj Pawar, Anshu Maheswari
170 [GO] 2020―May―31 A clinical, histopathological and laboratory study of 19 consecutive Italian paediatric patients with chilblain-like lesions: lights and shadows on the relationship with COVID-19 infection M. El Hachem, A. Diociaiuti, C. Concato, R. Carsetti, C. Carnevale, M. Ciofi Degli Atti, et al. (+9)
171 [GO] 2020―May―26 Cutaneous small-vessel vasculitis associated with novel 2019 coronavirus SARS-CoV-2 infection (COVID-19) M. Dominguez-Santas, B. Diaz-Guimaraens, P. Garcia Abellas, C. Moreno-Garcia del Real, P. Burgos-Blasco, A. Suarez-Valle
172 [GO] 2020―May―26 COVID-19 in a melanoma patient under treatment with checkpoint inhibition P. Schmidle, T. Biedermann, C. Posch
173 [GO] 2020―May―26 Erythema multiforme and Kawasaki disease associated with COVID-19 infection in children P. Labé, A. Ly, C. Sin, M. Nasser, E. Chapelon-Fromont, P. Ben Saïd, E. Mahé
174 [GO] 2020―May―26 The COVID-19 outbreak in dermatologic surgery: resetting clinical priorities E. Rossi, M. Trakatelli, L. Giacomelli, B. Ferrari, M. Francomano, G. Pellacani, C. Magnoni
175 [GO] 2020―May―26 A case of cefditoren-induced acute generalized exanthematous pustulosis during COVID-19 pandemics. Severe cutaneous adverse reactions are an issue I. Torres-Navarro, C. Abril-Pérez, J. Roca-Ginés, J. Sánchez-Arráez, R. Botella-Estrada
176 [GO] 2020―May―26 Are chilblain-like acral skin lesions really indicative of COVID-19? A prospective study and literature review A. Docampo-Simón, M.J. Sánchez-Pujol, G. Juan-Carpena, J.C. Palazón-Cabanes, E. Vergara-De Caso, L. Berbegal, et al. (+9)
177 [GO] 2020―May―26 Coronavirus 19 presenting with atypical Sweet's syndrome B. Taşkın, S. Vural, E. Altuğ, C. Demirkesen, E. Kocatürk, İ. Çelebi, et al. (+2)
178 [GO] 2020―May―26 Late onset of acral necrosis after SARS-CoV-2 infection resolution R. Balestri, S. Termine, G. Rech, C.R. Girardelli
179 [GO] 2020―May―22 Diversity of clinical appearance of cutaneous manifestations in the course of COVID-19 C. Guarneri, E. Venanzi Rullo, R. Gallizzi, M. Ceccarelli, S.P. Cannavò, G. Nunnari
180 [GO] 2020―May―22 COVID-19 and its implications for Dermatology and Venereology J. Ring
181 [GO] 2020―May―22 Cutaneous small vessel vasculitis secondary to COVID-19 infection: A case report A Mayor-Ibarguren, M Feito-Rodriguez, L Quintana Castanedo, E Ruiz-Bravo, D Montero Vega, P Herranz-Pinto
182 [GO] 2020―May―22 Protecting medical staff from skin injury/disease caused by personal protective equipment during epidemic period of COVID-19: experience from China H. Long, H. Zhao, A. Chen, Z. Yao, B. Cheng, Q. Lu
183 [GO] 2020―May―20 Acral purpuric lesions (Erythema multiforme type) associated with thrombotic vasculopathy in a child during the COVID-19 pandemic MF García-Gil, M García García, J Monte Serrano, L Prieto-Torres, M Ara-Martín
184 [GO] 2020―May―19 COVID-19 and Dermatology: A Comprehensive Guide for Dermatologists Dina Hassan Fahmy, Heba Saed El-Amawy, Marwa Ahmed El-Samongy, Aya Ashraf Foud, Sarah Hamdy Soliman, Aya El-Kady, et al. (+9)
185 [GO] 2020―May―19 Metastatic melanoma treatment with check point inhibitors in the COVID-19 era: experience from an Italian Skin Cancer Unit Pietro Quaglino, Paolo Fava, Matteo Brizio, Elena Marra, Marco Rubatto, Andrea Agostini, et al. (+3)
186 [GO] 2020―May―19 A clinicopathological study of 8 patients with COVID-19 pneumonia and a late-onset exanthema M Herrero-Moyano, TM Capusan, M Andreu-Barasoain, J Alcántara-González, M Ruano-Del Salado, ME Sánchez-Largo Uceda, et al. (+2)
187 [GO] 2020―May―19 Fever with Rash in COVID-19: Viral Exanthema or Secondary Lesions? M Goldust, A Abdelmaksoud, Z Shuang, C Xiang, AA Navarini
188 [GO] 2020―May―18 Teledermatology for COVID-19 cutaneous lesions: substitute or supplement? C Skayem, C Cassius, M Ben Kahla, C Fiani, L Frumholtz, M Mrad, et al. (+5)
189 [GO] 2020―May―18 A late onset widespread skin rash in a previous Covid-19 infected patient: viral or multidrug effect? N. Skroza, N. Bernardini, V. Balduzzi, A. Mambrin, A. Marchesiello, S. Michelini, et al. (+5)
190 [GO] 2020―May―18 Efficacy of hydrogel patches in preventing facial skin damage caused by mask compression in fighting against coronavirus disease-2019: a short-term, self-controlled study Liyun Dong, Liu Yang, Yan Li, Jing Yang, Xiangjie An, Liu Yang, et al. (+8)
191 [GO] 2020―May―16 Management of primary cutaneous lymphoma patients during COVID-19 pandemic: EORTC CLTF guidelines Maarten Vermeer Evangelia Papadavid, Julia Scaribrick, Pablo Ortiz Romero, Pietro Guaglino, Maarten Vermeer, Robert Knobler, et al. (+2)
192 [GO] 2020―May―12 Personal protective equipment induced facial dermatoses in healthcare workers managing COVID-19 cases Mehak Singh, Manoj Pawar, Atul Bothra, Anshu Maheshwari, Vivek Dubey, Apoorv Tiwari, Awatef Kelati
193 [GO] 2020―May―09 Dermatologic Surgery Training during the COVID-19 era José Alberto García-Lozano, Adrian Cuellar-Barboza, Verónica Garza-Rodríguez, Osvaldo Vázquez-Martínez, Jorge Ocampo-Candiani
194 [GO] 2020―May―09 Reply to “Acute urticaria with pyrexia as the first manifestations of a COVID-19 infection”: Urticaria-like lesions in COVID-19 patients are not really urticaria. A case with clinicopathologic correlation Pedro Rodríguez-Jiménez, Pablo Chicharro, Diego De Argila, Patricia Muñoz-Hernández, Mar Llamas-Velasco
195 [GO] 2020―May―09 Urticarial eruption in Coronavirus Disease 2019 (COVID-19) infection: a case report in Tangerang, Indonesia Catherine Gunawan, Allen Widysanto
196 [GO] 2020―May―09 Localised mid-face miliaria as a consequence of filtering face piece (FFP) respirator use during the COVID-19 pandemic V Campbell, D Middleton, J Donnelly, H Hunter
197 [GO] 2020―May―09 Histologic features of long lasting chilblain-like lesions in a pediatric COVID-19 patient A.G. Locatelli, E. Robustelli Test, P. Vezzoli, A. Carugno, E. Moggio, L. Consonni, et al. (+2)
198 [GO] 2020―May―09 “Toxic erythema” and eosinophilia associated to tocilizumab therapy in a COVID-19 patient A Sernicola, G Carnicelli, M Di Fraia, C Chello, C Furlan, R Muharremi, et al. (+2)
199 [GO] 2020―May―09 COVID-19 pulmonary infection in erythrodermic psoriatic patient with oligodendroglioma: safety and compatibility of apremilast with critical intensive care management Cristina Mugheddu, Laura Pizzatti, Silvia Sanna, Laura Atzori, Franco Rongioletti
200 [GO] 2020―May―09 Acute Generalized Exanthematous Pustulosis with Erythema Multiforme-Like lesions in a COVID-19 woman E. Robustelli Test, P. Vezzoli, A. Carugno, F. Raponi, A. Gianatti, F. Rongioletti, P. Sena
201 [GO] 2020―May―09 Atypical erythema multiforme palmar plaques lesions due to Sars-Cov-2 Hicham Janah, Ali Zinebi, Jalal Elbenaye
202 [GO] 2020―May―09 SARS-CoV-2 asymptomatic infection in a patient under treatment with dupilumab Francesca Caroppo, Giulia Biolo, Anna Belloni Fortina
203 [GO] 2020―May―07 Drug-induced vasculitis in a patient with COVID-19 A. Vanegas Ramirez, D. Efe, M. Fischer
204 [GO] 2020―May―07 Evolution of COVID-19 infection in 4 psoriatic patients treated with biological drugs A. Conti, C. Lasagni, L. Bigi, G. Pellacani
205 [GO] 2020―May―07 Acro-ischemia in hospitalized COVID-19 patients A. Suarez-Valle, D. Fernandez-Nieto, B. Diaz-Guimaraens, M. Dominguez-Santas, I. Carretero, B. Perez-Garcia
206 [GO] 2020―May―07 Symmetric cutaneous vasculitis in COVID-19 pneumonia Laura Castelnovo, Francesca Capelli, Antonio Tamburello, Paola Maria Faggioli, Antonino Mazzone
207 [GO] 2020―May―07 SARS-CoV-2 possible contamination of genital area: implications for sexual and vertical transmission routes M Delfino, M Guida, A Patrì, L Spirito, L Gallo, G Fabbrocini
208 [GO] 2020―May―07 Improvement of SARS-CoV2 symptoms following Guselkumab injection in a psoriatic patient F. Benhadou, V. Del Marmol
209 [GO] 2020―May―03 Hand disinfection in the combat against Covid-19 M Goldust, A Abdelmaksoud, AA Navarini
210 [GO] 2020―May―03 Estimated effect of COVID-19 lockdown on melanoma thickness and prognosis: a rate of growth model Antonio Tejera-Vaquerizo, Eduardo Nagore
211 [GO] 2020―May―03 Occupational skin conditions on the frontline: A survey among 484 Chinese healthcare professionals caring for Covid-19 patients Shiyao Pei, Yadong Xue, Shuang Zhao, Navarini Alexander, Goldust Mohamad, Xiang Chen, Mingzhu Yin
212 [GO] 2020―May―02 COVID-19 epidemic: Skin protection for health care workers must not be ignored Bin Zhang, Ruijie Zhai, Lin Ma
213 [GO] 2020―May―02 Histological pattern in Covid-19 induced viral rash Corrado Zengarini, Gionathan Orioni, Alessandra Cascavilla, Clara Horna Solera, Ciro Fulgaro, Cosimo Misciali, et al. (+2)
214 [GO] 2020―May―02 Pityriasis rosea as a cutaneous manifestation of COVID-19 infection Amir Hooshang Ehsani, Maryam Nasimi, Zeinab Bigdelo
215 [GO] 2020―May―02 The use of Google trends for acral symptoms during COVID-19 outbreak in France Nicolas Kluger, Yannis Scrivener
216 [GO] 2020―May―02 Occurrence of SARS-CoV-2 during mycophenolate mofetil treatment for pemphigus R. Balestri, G. Rech, C.R. Girardelli
217 [GO] 2020―May―02 SARS-CoV-2 infection in a psoriatic patient treated with IL-23 inhibitor R. Balestri, G. Rech, C.R. Girardelli
218 [GO] 2020―May―01 European Task Force on Contact Dermatitis statement on coronavirus 19 disease (COVID-19) outbreak and the risk of adverse cutaneous reactions Anna Balato, Fabio Ayala, Magnus Bruze, Marie-Noëlle Crepy, Margarida Gonçalo, Jeanne Duus Johansen, et al. (+10)
219 [GO] 2020―Apr―27 No evidence of increased risk for COVID-19 infection in patients treated with Dupilumab for atopic dermatitis in a high-epidemic area - Bergamo, Lombardy, Italy A. Carugno, F. Raponi, A.G. Locatelli, P. Vezzoli, D.M. Gambini, M. Di Mercurio, et al. (+2)
220 [GO] 2020―Apr―27 Vascular skin symptoms in COVID-19: a french observational study JD Bouaziz, T Duong, M Jachiet, C Velter, P Lestang, C Cassius, et al. (+6)
221 [GO] 2020―Apr―25 Expert recommendations for the management of autoimmune bullous diseases during the COVID-19 pandemic M. Kasperkiewicz, E. Schmidt, J.A. Fairley, P. Joly, A.S. Payne, M.L. Yale, et al. (+2)
222 [GO] 2020―Apr―25 Skin cancer triage and management during COVID-19 pandemic Luca Tagliaferri, Alessandro Di Stefani, Giovanni Schinzari, Bruno Fionda, Ernesto Rossi, Laura Del Regno, et al. (+5)
223 [GO] 2020―Apr―24 Acral cutaneous lesions in the Time of COVID-19 S. Recalcati, T. Barbagallo, L.A. Frasin, F. Prestinari, A. Cogliardi, M.C. Provero, et al. (+3)
224 [GO] 2020―Apr―24 Chilblain-like lesions during COVID-19 epidemic: a preliminary study on 63 patients Vincenzo Piccolo, Iria Neri, Cesare Filippeschi, Teresa Oranges, Giuseppe Argenziano, Vincenzo Claudio Battarra, et al. (+9)
225 [GO] 2020―Apr―24 Cutaneous manifestation of COVID-19 in images: A case report R. Avellana Moreno, Estela Villa, V. Avellana Moreno, C. Estela Villa, Moreno Aparicio, Avellana Fontanella
226 [GO] 2020―Apr―24 Acute urticaria with pyrexia as the first manifestations of a COVID-19 infection C. van Damme, E. Berlingin, S. Saussez, O. Accaputo
227 [GO] 2020―Apr―24 Did Whatsapp ® reveal a new cutaneous COVID-19 manifestation? TA Duong, C Velter, M Rybojad, C Comte, M Bagot, L Sulimovic, JD Bouaziz
228 [GO] 2020―Apr―24 Mass quarantine measures in the time of COVID-19 pandemic: psycho-social implications for chronic skin conditions and a call for qualitative studies S. Garcovich, F.S Bersani, A. Chiricozzi, C. De Simone
229 [GO] 2020―Apr―24 Cutaneous manifestations in COVID-19: the experiences of Barcelona and Rome A. Tammaro, G.A.R. Adebanjo, F.R. Parisella, A. Pezzuto, J. Rello
230 [GO] 2020―Apr―24 Safety of dupilumab in severe atopic dermatitis and infection of Covid-19: two case reports S. Ferrucci, M. Romagnuolo, L. Angileri, E. Berti, S. Tavecchio
231 [GO] 2020―Apr―24 SARS-CoV-2 infection presenting as a febrile rash F Amatore, N Macagno, M Mailhe, B Demarez, C Gaudy-Marqueste, JJ Grob, et al. (+3)
232 [GO] 2020―Apr―22 Dermatologists and SARS-CoV-2: The impact of the pandemic on daily practice P Gisondi, S Piaserico, A Conti, L Naldi
233 [GO] 2020―Apr―21 Comment on “Cutaneous manifestations in COVID-19: a first perspective ” by Recalcati S M. Hedou, F. Carsuzaa, E. Chary, E. Hainaut, F. Cazenave-Roblot, M. Masson Regnault
234 [GO] 2020―Apr―17 Skin Reactions to Non-glove Personal Protective Equipment: An Emerging Issue in the COVID-19 Pandemic Mehdi Gheisari, Farnaz Araghi, Hamideh Moravvej, Mohammadreza Tabary, Sahar Dadkhahfar
235 [GO] 2020―Apr―17 Covid-19: Countermeasure for N95 mask-induced pressure sore ZhiQiang Yin
236 [GO] 2020―Apr―17 Should SARS-CoV-2 influence immunosuppressive therapy for autoimmune blistering diseases? Ambra Di Altobrando, Annalisa Patrizi, Federico Bardazzi
237 [GO] 2020―Apr―15 Viral exanthem in COVID-19, a clinical enigma with biological significance Chia-Jui Su, Chih-Hung Lee
238 [GO] 2020―Apr―15 COVID-19 and Cutaneous manifestations Rujittika Mungmungpuntipantip, Viroj Wiwanitkit
239 [GO] 2020―Apr―15 Face the COVID-19 emergency: measures applied in an Italian Dermatologic Clinic C. Marasca, A. Ruggiero, M.C. Annunziata, G. Fabbrocini, M. Megna
240 [GO] 2020―Apr―15 Urticarial eruption in COVID-19 infection D. Henry, M. Ackerman, E. Sancelme, A. Finon, E. Esteve
241 [GO] 2020―Apr―15 Comment on: Cutaneous manifestations in COVID-19: a first perspective. Safety concerns of clinical images and skin biopsies D Fernandez-Nieto, D Ortega-Quijano, G Segurado-Miravalles, C Pindado-Ortega, M Prieto-Barrios, J Jimenez-Cauhe
242 [GO] 2020―Apr―15 Cutaneous manifestations in COVID-19: a new contribution Andrea Estébanez, Leticia Pérez-Santiago, Esmeralda Silva, Santiago Guillen-Climent, Alejandro García-Vázquez, M. Dolores Ramón
243 [GO] 2020―Apr―15 A distinctive skin rash associated with Coronavirus Disease 2019 ? A. Mahé, E. Birckel, S. Krieger, C. Merklen, L. Bottlaender
244 [GO] 2020―Apr―15 Psoriasis health care in the time of the coronavirus pandemic: insights from dedicated centers in sardinia (Italy) L. Atzori, C. Mugheddu, G. Addis, S. Sanna, R. Satta, C. Ferreli, et al. (+3)
245 [GO] 2020―Apr―15 SARS-CoV-2 infection in a psoriatic patient treated with IL-23 inhibitor F. Messina, S. Piaserico
246 [GO] 2020―Mar―29 Art of performing dermoscopy during the times of coronavirus disease (COVID-19): Simple change in approach can save the day! Deepak Jakhar, Ishmeet Kaur, Subuhi Kaul
247 [GO] 2020―Mar―29 European Task Force on Atopic Dermatitis (ETFAD) statement on severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2)-infection and atopic dermatitis Andreas Wollenberg, Carsten Flohr, Dagmar Simon, Michael J Cork, Jacob P. Thyssen, Thomas Bieber, et al. (+27)
248 [GO] 2020―Mar―27 What dermatologists could do to cope with the novel coronavirus (SARS-CoV-2): a dermatologist’s perspective from China Hanlin Zhang, Keyun Tang, Rouyu Fang, Qiuning Sun
249 [GO] 2020―Mar―27 Medical education and care in dermatology during the SARS-CoV2 pandemia: challenges and chances M Reinholz, LE French
250 [GO] 2020―Mar―26 Cutaneous manifestations in COVID-19: a first perspective S. Recalcati
251 [GO] 2020―Mar―23 Dermatology staff participate in fight against Covid-19 in China Yue Zheng, Wei Lai
252 [GO] 2020―Mar―23 Global coronavirus pandemic (2019-nCOV): Implication for an Italian medium size dermatological clinic of a ii level hospital G. Radi, F. Diotallevi, A. Campanati, A. Offidani


[de][en]

Last change 2021―Jun―30 20:09:44 UTC

© Daten-Quadrat 2021       Done in 0.009 sec